NovaBridge Biosciences NBP
NASDAQ NBP
$1.36 +0.02 (+1.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

NovaBridge Biosciences (NBP) Return on Sales [ROS] (2019 - 2023)

Updated

NovaBridge Biosciences' Return on Sales [ROS] came in at -789260.00% for Q4 2023, down 785884.13 percentage points from the prior quarter.

Analysis

NovaBridge Biosciences (NBP) Return on Sales [ROS] (2019 - 2023) Analysis & Trends

For FY2023, NovaBridge Biosciences' Return on Sales [ROS] was -31313.96%, down 12401.77 percentage points from FY2022.

  • Return on Sales [ROS] has declined in each of the last three years, with a five-year change of -30498.35 percentage points (FY2018 to FY2023).
  • Going back by year, Return on Sales [ROS] was -18912.18% in FY2022 (-16587.40 pp), -2324.79% in FY2021 (-2319.51 pp), -5.27% in FY2020 (+4878.23 pp) and -4883.50% in FY2019 (-4067.90 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 NovaBridge Biosciences 149.78 Mn 149.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -789,260.00%
Sep 30, 2023 -3,375.87%
Jun 30, 2023 -7,578.62%
Dec 31, 2020 60.24%
Sep 30, 2019 -2,042.94%
API Access

NovaBridge Biosciences Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NBP&period=max&api_key=YOUR_API_KEY